Skip to content

Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter

Evaluation of the Effectiveness and Security of the Prophylactic Platelet Transfusion in Thrombocytopenic Patients Requiring the Placement of a Central Venous Catheter

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02906878
Acronym
PLATCAT
Enrollment
30
Registered
2016-09-20
Start date
2016-06-30
Completion date
2017-07-31
Last updated
2016-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Venous Catheter Placement, Thrombopenia

Keywords

Intensive Care, Haematology, Platelets prophylactic transfusion

Brief summary

PLATCAT study's purpose is to evaluate platelet kinetics after platelet transfusion

Interventions

PROCEDUREPlatelets transfusion

Prophylactic platelet transfusion in thrombocytopenic patients for the placement of a central venous catheter

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admission en haematology unit * Need for a central venous catheter * Thrombopenia \< 50 G/L

Exclusion criteria

* Patient protected by law * Pregnant or breastfeeding women * Peripheral thrombopenia * Patient admitted in Intensive Care Unit

Design outcomes

Primary

MeasureTime frameDescription
72 hours thrombocythemia kinetics after a platelet transfusion72 hours post transfusionBlood drawing a H-1:00, H+0:10, H+1:00, H+4:00, H+24h00, H+72:00 Evaluation of platelets count on sodium citrate tube.

Secondary

MeasureTime frameDescription
Transfusion Safety - assessed by Troubles during processOne day after transfusionTroubles during process (pneumothorax, laying failure, hematoma) Hematoma at H+24:00 Immunisation anti HLA,HPA
Transfusion EfficacyOne month after transfusionNumber of blood or platelets transfusion
Description of patients treatmentOne week before and one month after transfusionType of received chemotherapy

Countries

France

Contacts

Primary ContactNicolas LEROLLE, MD PhD
NiLerolle@chu-angers.fr+33241353478
Backup ContactAline SCHMIDT, MD
alschmidt@chu-angers.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026